QIAGEN acquisition of N-of-One, Inc.
Acquisition07/01/2019
QIAGEN announced its acquisition of N-of-One, Inc., a molecular-oncology interpretation business. The issuer's transaction summary states that the acquisition was completed in January 2019 using cash reserves. Its MarkerMine database and interpretation services supplemented QIAGEN Clinical Insight. Financial terms were not disclosed.
Type
Acquisition
Announced
07/01/2019
Amount
Financial data requires access
Reported parties
QIAGEN N.V.; N-of-One, Inc.